View Older Stories View More Recent Stories

Nov 17, 2009 07:20AM Merriman Curhan Ford Initiates Coverage on Antares Pharma (AIS) with a Buy; Cutting Edge Drug Delivery Business

Nov 16, 2009 04:38PM Merriman Curhan Ford (MERR) Reports Large Q3 Loss

Nov 16, 2009 02:12PM Unusual 11 Mid-Day Movers 11/16: SPEX, NLST, DRAM, XJT Higher; PARD, CRXX, CAEI, CHIO Lower

Nov 16, 2009 11:40AM Oppenheimer, BMO, Merriman, Needham Downgrade Poinard (PARD) Following Negative Picoplatin Data

Nov 16, 2009 11:10AM Notable Analyst Rating Changes 11/16: COH, JWN, GNK, ESEA, SVA, YGE Upgraded; PARD, GPS, JCP, DLTR Downgraded

Nov 16, 2009 10:11AM Morning Movers 11/16: SPEX, NLST, XJT, NABI, KHD, IBKC, SPA Higher; PARD, CRXX, CAEI Lower

Nov 16, 2009 09:31AM Merriman Curhan Ford Downgrades Poniard Pharmaceuticals (PARD) to Neutral After Disappointing Phase III SPEAR Trial Results

Nov 16, 2009 07:43AM Merriman Curhan Ford Downgrades ZAGG, Inc. (ZAGG) from Buy to Neutral; 3Q09 Results Were Mixed

Nov 12, 2009 04:50PM Compellent Technologies (CML) Files 3M Common Share Offering; 2.7M To Be Sold by Shareholders

Nov 11, 2009 01:34PM Merriman Curhan Ford Reiterates a 'Buy' on Regeneron (REGN); Raising Target Range

Nov 5, 2009 11:25AM Notable Analyst Rating Changes 11/5: PALM, VALE, TRW, ONNN, MDT, SPWRA Upgraded; CMCSA, ARO, DPTR, GRMN TEX Downgraded

Nov 5, 2009 07:54AM Merriman Curhan Ford Initiates Coverage on Isilon Systems (ISLN) with a Neutral

Nov 5, 2009 07:51AM Merriman Curhan Ford Initiates Coverage on YM BioSciences (YMI) with a Buy; Intriguing Opportunity

Nov 5, 2009 07:46AM Merriman Curhan Ford Downgrades Geeknet (LNUX) to Neutral; Online Media Segment Turnaround Taking Longer Than Expected

Nov 5, 2009 07:33AM Merriman Curhan Starts Novavax (NVAX) at Buy, $6-$8 Tgt

Nov 4, 2009 11:11AM Merriman Curhan Positive On Celldex Therapeutics (CLDX) After Results and Ahead of Events

Nov 3, 2009 11:53AM InterMune (ITMN) Higher Following INFORM-1 Trial Data

Nov 3, 2009 07:05AM Merriman Curhan Ford Downgrades Carmike Cinemas (CKEC) to Neutral; Cautious on Near-Term Ability

Oct 30, 2009 01:24PM Merriman Curhan Ford Reiterates 'Buy' Geron Corporation (GERN); Important Stem Cell Visibility

Oct 28, 2009 11:48AM Notable Analyst Rating Changes 10/28: TXN, MOT, TGT, WYNN, ILMN Upgraded; APOL, SNDK, NVDA, X, VCLK Downgraded

Oct 28, 2009 10:39AM Morning Movers 10/28: CSBC, QTM, ANIK, RSYS, PEET, WSII Higher; CALC, KSP, PSYS, VCLK, VPHM, GT Lower

Oct 28, 2009 08:49AM Cyclacel Pharmaceuticals (CYCC) Moves Up On Merriman Curhan's New "Buy" Rating, Aggressive Price Target

Oct 28, 2009 07:45AM Merriman Curhan Ford Reiterates a 'Buy' on Repligen (RGEN); Slow & Steady Wins The Race

Oct 28, 2009 07:41AM Merriman Curhan Ford Downgrades ValueClick (VCLK) to Neutral; Negative Growth in Revenues

Oct 28, 2009 07:38AM Merriman Curhan Ford Downgrades Switch and Data (SDXC) to Neutral; Continue Recommending Shares of EQIX

Oct 28, 2009 07:34AM Merriman Curhan Ford Initiates Coverage on Cyclacel Pharmaceuticals (CYCC) with a Buy

Oct 19, 2009 01:53PM Merriman Curhan Ford Reiterates a 'Buy' on Cree (CREE); Raises PT & Estimates

Oct 19, 2009 07:08AM Merriman Curhan Ford Upgrades Geron (GERN) to Buy; Catalysts Starting in November

Oct 19, 2009 07:03AM Merriman Curhan Ford Upgrades China Automotive Systems (CAAS) to Buy

Oct 15, 2009 07:03AM Merriman Curhan Ford Upgrades Acorda Therapeutics (ACOR) to Buy; FDA in Coach's Corner

Oct 14, 2009 07:19AM Merriman Curhan Ford Initiates Coverage on General Steel Holdings (GSI) with a Buy; Current Valuation Likely Limits N/T Downside Risk

Oct 13, 2009 07:24AM Merriman Curhan Ford Initiates Coverage on interCLICK, Inc. (ICLK) with a Buy

Oct 12, 2009 04:02PM Vion Pharma (VION) Hires Merriman Curhan Ford to Evaluate Strategic Alternatives

Oct 12, 2009 10:44AM Merriman Curhan Ford Maintains a 'Buy' on Depomed (DEPO); Lowers PT Range

Oct 8, 2009 10:39AM Merriman Curhan Ford Reiterates a 'Buy' on AIXTRON AG (AIXG); Raises Estimates

Oct 8, 2009 07:53AM Merriman Curhan Ford Reiterates a 'Buy' on KIT digital (KITD); Raises Valuation Range

Oct 6, 2009 07:16AM Merriman Curhan Ford Reiterates a 'Buy' on Fairchild Semiconductor (FCS); Raises Estimate Ahead of Q3 Results

Oct 6, 2009 07:13AM Merriman Curhan Ford Reiterates a 'Buy' on Local.com Corp. (LOCM); Raises Estimates on Q3 Outperformance

Oct 5, 2009 03:16PM Merriman Curhan Ford Said DepoMed's (DEPO) Lack of Wall Street Attention Is About to Change

Oct 5, 2009 01:38PM Unusual 11 Mid-Day Movers 10/05: ROIAK, DEPO, AVII, CMLS Higher; FOLD, SGEN, SCLN, REED Lower

Oct 5, 2009 10:16AM Morning Movers 10/05: DEPO, AVII, OPTV, CRXX, UCTT, CPRX Higher; FOLD, FTBK, SGEN, SCLN, REED Lower

Oct 5, 2009 07:49AM Merriman Curhan Ford Initiates Coverage on Depomed (DEPO) with a Buy

Oct 2, 2009 09:44AM Morning Movers 10/02: TELK, ALY, GNVC, CIT Higher; ETRM, BNVI, KEG, LTM, PGH, GRT Lower

Oct 2, 2009 07:44AM Merriman Curhan Ford Downgrades eHealth (EHTH) to Neutral

Oct 2, 2009 07:04AM Merriman Curhan Ford Reiterates a 'Buy' on Celldex Therapeutics (CLDX); Raises Target Range to $14-15

Oct 2, 2009 07:01AM Merriman Curhan Ford Initiates Coverage on GenVec (GNVC) with a Buy; Intriguing Opportunity

Oct 1, 2009 01:34PM Merriman Curhan Pounds The Table On Facet Biotechnology (FACT) After Board Formally Rejects Biogen Offer

Oct 1, 2009 11:42AM Merriman Curhan Ford Reiterated their Buy on Halozyme (HALO) After Data

Oct 1, 2009 09:59AM Catalyst Pharmaceutical (CPRX) Surges On Plans to Continue Development of Addiction Treatment

Oct 1, 2009 07:44AM Merriman Curhan Ford Upgrades Catalyst Pharmaceuticals (CPRX) to Neutral

View More Recent Stories View Older Stories